20 Biotechnology Stocks Moving In Tuesday's After-Market Session

Gainers

• Genprex, Inc. GNPX stock increased by 18.3% to $1.36 during Tuesday's after-market session.

• BioCryst Pharmaceuticals, Inc. BCRX shares rose 7.8% to $3.16. According to the most recent rating by Bank of America, on November 15, the current rating is at Buy.

• Menlo Therapeutics, Inc. MNLO stock rose 7.4% to $6.93.

• Sunesis Pharmaceuticals, Inc. SNSS stock increased by 7.4% to $0.58.

• KemPharm, Inc. KMPH stock increased by 7.0% to $0.44. The most recent rating by H.C. Wainwright, on November 20, is at Buy, with a price target of $2.50.

• Viking Therapeutics, Inc. VKTX shares rose 5.5% to $7.48.

• Athersys, Inc. ATHX stock increased by 4.7% to $1.34.

• Titan Pharmaceuticals, Inc. TTNP shares moved upwards by 4.4% to $0.39.

• Foamix Pharmaceuticals, Inc. FOMX stock surged 4.3% to $4.82.

• Bellicum Pharmaceuticals, Inc. BLCM stock rose 3.7% to $2.23.

• Oncolytics Biotech, Inc. ONCY stock moved upwards by 3.7% to $3.68.

• Trillium Therapeutics, Inc. TRIL stock increased by 3.6% to $2.87.

• Aduro Biotech, Inc. ADRO stock increased by 3.5% to $1.46. According to the most recent rating by Cowen & Co., on January 10, the current rating is at Market Perform.

• Aevi Genomic Medicine, Inc. GNMX shares surged 3.3% to $0.20.

• Intrexon, Inc. XON shares moved upwards by 3.1% to $5.80.

• Intec Pharma, Inc. NTEC stock rose 3.0% to $0.58.

Losers

• Novavax, Inc. NVAX stock plummeted 10.7% to $8.77 during Tuesday's after-market session.

• Sophiris Bio, Inc. SPHS stock decreased by 8.3% to $0.80.

• Adaptimmune Therapeutics, Inc. ADAP stock declined 5.3% to $3.92.

• DBV Technologies, Inc. DBVT stock decreased by 3.6% to $12.00. The most recent rating by Stifel, on January 09, is at Buy, with a price target of $18.00.